Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 449 articles:
HTML format



Single Articles


    August 2021
  1. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
    Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
    J Am Coll Cardiol. 2021;78:543-544.
    PubMed    


  2. SHCHENDRYGINA A, Mewton N, Meznar AZ
    Advanced Heart Failure and Angiotensin System Fascinating Complexities.
    J Am Coll Cardiol. 2021;78:541-542.
    PubMed    


    July 2021
  3. ROSSIGNOL P, Pitt B
    Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
    J Am Coll Cardiol. 2021;78:344-347.
    PubMed    


  4. ITKIN M, Rockson SG, Burkhoff D
    Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:278-290.
    PubMed     Abstract available


  5. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
    Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:66-76.
    PubMed     Abstract available


  6. FUSTER JJ
    Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
    J Am Coll Cardiol. 2021;78:53-55.
    PubMed    


  7. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
    Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    J Am Coll Cardiol. 2021;78:42-52.
    PubMed     Abstract available


    June 2021
  8. LAM CSP, Solomon SD
    Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:3217-3225.
    PubMed     Abstract available


  9. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    PubMed    


  10. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    PubMed     Abstract available


  11. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
    Pericardial Fat and the Risk of Heart Failure.
    J Am Coll Cardiol. 2021;77:2638-2652.
    PubMed     Abstract available


    May 2021
  12. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    PubMed     Abstract available


  13. GOTTLIEB SH
    Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
    J Am Coll Cardiol. 2021;77:2320-2322.
    PubMed    


  14. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
    Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
    J Am Coll Cardiol. 2021;77:2307-2319.
    PubMed     Abstract available


  15. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
    New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
    J Am Coll Cardiol. 2021;77:2260-2262.
    PubMed    


  16. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
    Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
    PubMed     Abstract available


    April 2021
  17. MANCINI D, Gibson GT
    Impact of Pneumonia in Heart Failure Patients.
    J Am Coll Cardiol. 2021;77:1974-1976.
    PubMed    


  18. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
    Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1961-1973.
    PubMed     Abstract available


  19. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
    Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1952-1953.
    PubMed    


  20. RAUH MJ
    Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2021;77:1760-1762.
    PubMed    


  21. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
    Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1747-1759.
    PubMed     Abstract available


  22. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
    Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
    J Am Coll Cardiol. 2021;77:1731-1743.
    PubMed     Abstract available


    March 2021
  23. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
    Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
    J Am Coll Cardiol. 2021;77:1454-1469.
    PubMed     Abstract available


  24. GREENE SJ, Khan MS
    Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
    J Am Coll Cardiol. 2021;77:1408-1411.
    PubMed    


  25. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
    Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
    J Am Coll Cardiol. 2021;77:1397-1407.
    PubMed     Abstract available


  26. KOSIBOROD MN, Vaduganathan M
    SGLT-2 Inhibitors in Heart Failure: Volume or Value?
    J Am Coll Cardiol. 2021;77:1393-1396.
    PubMed    


  27. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;77:1381-1392.
    PubMed     Abstract available


  28. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
    SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
    J Am Coll Cardiol. 2021;77:1375-1377.
    PubMed    


  29. MCCULLOUGH PA, Rahimi G, Tecson KM
    Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1222-1224.
    PubMed    


  30. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
    Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    J Am Coll Cardiol. 2021;77:1211-1221.
    PubMed     Abstract available


  31. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
    3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1029-1040.
    PubMed     Abstract available


    February 2021
  32. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
    Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
    J Am Coll Cardiol. 2021;77:1023-1025.
    PubMed    


  33. FELKER GM, Greene SJ
    Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
    J Am Coll Cardiol. 2021;77:709-712.
    PubMed    


  34. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
    Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:695-708.
    PubMed     Abstract available


  35. GOODLIN SJ
    RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
    J Am Coll Cardiol. 2021;77:504-505.
    PubMed    


  36. CHUZI S, Khan SS, Pak ES
    Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
    J Am Coll Cardiol. 2021;77:501-505.
    PubMed    


  37. FRISK M, Le C, Shen X, Roe AT, et al
    Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:405-419.
    PubMed     Abstract available


    January 2021
  38. GOLDBERG LR
    The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
    J Am Coll Cardiol. 2021;77:256-258.
    PubMed    


  39. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
    Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
    J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
    PubMed    


  40. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
    J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
    PubMed    


    December 2020
  41. PAGANI FD
    Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
    J Am Coll Cardiol. 2020;76:2965-2967.
    PubMed    


  42. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
    Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
    J Am Coll Cardiol. 2020;76:2940-2951.
    PubMed     Abstract available


  43. ALAHMAD B, Khraishah H
    Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
    J Am Coll Cardiol. 2020;76:2875-2877.
    PubMed    


  44. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
    Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
    J Am Coll Cardiol. 2020;76:2862-2874.
    PubMed     Abstract available


  45. GUPTA DK, Crescenzi R, Aday AW
    Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2830-2833.
    PubMed    


  46. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
    Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2817-2829.
    PubMed     Abstract available


  47. JANUZZI JL JR, Ibrahim NE
    Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
    J Am Coll Cardiol. 2020;76:2752-2754.
    PubMed    


  48. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
    Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2740-2751.
    PubMed     Abstract available


  49. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
    Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:2671-2681.
    PubMed     Abstract available


  50. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
    Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:2595-2606.
    PubMed     Abstract available


    November 2020
  51. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
    2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
    PubMed    


  52. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
    Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
    J Am Coll Cardiol. 2020;76:2334-2348.
    PubMed     Abstract available


  53. FASELIS C, Fonarow GC, Ahmed A
    Reply: Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418-2420.
    PubMed    


  54. DAUW J, Mullens W
    Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418.
    PubMed    


  55. PANJRATH GS, Krepp J
    COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
    J Am Coll Cardiol. 2020;76:2349-2351.
    PubMed    


  56. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
    Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2417-2418.
    PubMed    


  57. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
    Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2416-2417.
    PubMed    


  58. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
    Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
    PubMed     Abstract available


  59. VELAZQUEZ EJ, Reinhardt SW
    Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
    J Am Coll Cardiol. 2020;76:2086-2088.
    PubMed    


    October 2020
  60. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
    Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2040-2041.
    PubMed    


  61. FUDIM M, Soloveva A
    Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2038-2039.
    PubMed    


  62. LIU PP, Al-Khalaf M, Blet A
    Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
    J Am Coll Cardiol. 2020;76:1995-1998.
    PubMed    


  63. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
    Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1982-1994.
    PubMed     Abstract available


  64. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
    Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
    J Am Coll Cardiol. 2020;76:1919-1930.
    PubMed     Abstract available


  65. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
    2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
    PubMed    


  66. KITTLESON MM
    The Trials of Women in Cardiology.
    J Am Coll Cardiol. 2020;76:1931-1933.
    PubMed    


  67. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
    Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1795-1807.
    PubMed     Abstract available


  68. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
    Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
    J Am Coll Cardiol. 2020;76:1717-1718.
    PubMed    


  69. MEWTON N, Sebbag L, Bochaton T
    Other Things Behind the Low Rate of Heart Failure Trial Publication.
    J Am Coll Cardiol. 2020;76:1716-1717.
    PubMed    


  70. MEHMOOD M
    Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
    J Am Coll Cardiol. 2020;76:1715-1716.
    PubMed    


    September 2020
  71. SUTHAHAR N, Lau ES, Blaha MJ, Paniagua SM, et al
    Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.
    J Am Coll Cardiol. 2020;76:1455-1465.
    PubMed     Abstract available


  72. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
    Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
    J Am Coll Cardiol. 2020;76:1501-1502.
    PubMed    


  73. XIANG D, Xiang X, Zhang W, Yi S, et al
    Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
    J Am Coll Cardiol. 2020;76:1318-1324.
    PubMed     Abstract available


  74. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
    Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:1305-1314.
    PubMed     Abstract available


  75. KOSMALA W
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: How to Fight Allied Enemies.
    J Am Coll Cardiol. 2020;76:1065-1067.
    PubMed    


  76. REDDY YNV, Obokata M, Verbrugge FH, Lin G, et al
    Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1051-1064.
    PubMed     Abstract available


  77. AMBROSY AP, Braunwald E, Morrow DA, DeVore AD, et al
    Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.
    J Am Coll Cardiol. 2020;76:1034-1048.
    PubMed     Abstract available


  78. GOTTLIEB SS, Ahmed T
    Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
    J Am Coll Cardiol. 2020;76:1049-1050.
    PubMed    


  79. GUAZZI M, Ghio S, Adir Y
    Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1102-1111.
    PubMed     Abstract available


  80. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
    Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;76:1084-1101.
    PubMed     Abstract available


    August 2020
  81. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
    Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    J Am Coll Cardiol. 2020;76:930-941.
    PubMed     Abstract available


  82. SANNINO A, Sudhakaran S, Milligan G, Chowdhury A, et al
    Effectiveness of Medical Therapy for Functional Mitral Regurgitation in Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:883-884.
    PubMed    


  83. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    PubMed     Abstract available


  84. ROWIN EJ, Maron BJ, Maron MS
    The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36310.
    PubMed    


  85. DALZELL JR, Connolly EC, Cannon JA
    The LVAD in the management of advanced heart failure due to hypertrophic cardiomyopathy.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36312.
    PubMed    


  86. BUTLER J, Khan MS
    Heart Failure Prevention for All: Treatment Is Good, Prevention Is Better.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36305.
    PubMed    


  87. WILCOX JE, Fang JC, Margulies KB, Mann DL, et al
    Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2020;76:719-734.
    PubMed     Abstract available


  88. FASELIS C, Arundel C, Patel S, Lam PH, et al
    Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    J Am Coll Cardiol. 2020;76:669-679.
    PubMed     Abstract available


  89. COX ZL, Stevenson LW
    The Weight of Evidence for Diuretics and Parachutes.
    J Am Coll Cardiol. 2020;76:680-683.
    PubMed    


  90. BAYES-GENIS A, Nunez J, Lupon J
    Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
    J Am Coll Cardiol. 2020;76:515-517.
    PubMed    


  91. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
    Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
    J Am Coll Cardiol. 2020;76:503-514.
    PubMed     Abstract available


    July 2020
  92. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    PubMed     Abstract available


  93. ZILE MR, Lindenfeld J, Weaver FA, Zannad F, et al
    Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1-13.
    PubMed     Abstract available


  94. JANUZZI JL JR, Ibrahim NE
    The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
    J Am Coll Cardiol. 2020;76:14-16.
    PubMed    


    June 2020
  95. PSOTKA MA, Latta F, Cani D, Fiuzat M, et al
    Publication Rates of Heart Failure Clinical Trials Remain Low.
    J Am Coll Cardiol. 2020;75:3151-3161.
    PubMed     Abstract available


  96. MEHRA MR, Grazette LP
    Untimely Trial Publication: A Sin of Omission?
    J Am Coll Cardiol. 2020;75:3162-3163.
    PubMed    


  97. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
    Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    J Am Coll Cardiol. 2020;75:3033-3043.
    PubMed     Abstract available


  98. KAPUR NK
    RESPONSE: Hybrid Training for Interventional, Heart Failure, and Critical Care Medicine.
    J Am Coll Cardiol. 2020;75:2987-2988.
    PubMed    


  99. SOMERS VK, Karim S
    Upright Cheyne-Stokes Respiration in Heart Failure: Look But Don't Touch.
    J Am Coll Cardiol. 2020;75:2947-2949.
    PubMed    


  100. GIANNONI A, Gentile F, Sciarrone P, Borrelli C, et al
    Upright Cheyne-Stokes Respiration in Patients With Heart Failure.
    J Am Coll Cardiol. 2020;75:2934-2946.
    PubMed     Abstract available


  101. PARKER WF, Chung K, Anderson AS, Siegler M, et al
    Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
    J Am Coll Cardiol. 2020;75:2906-2916.
    PubMed     Abstract available


  102. FERREIRA JP, Butler J, Rossignol P, Pitt B, et al
    Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:2836-2850.
    PubMed     Abstract available


  103. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
    Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:2851-2862.
    PubMed     Abstract available


    May 2020
  104. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
    Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
    J Am Coll Cardiol. 2020;75:2642-2644.
    PubMed    


  105. JAVAHERI A, Allegood JC, Cowart LA, Chirinos JA, et al
    Circulating Ceramide 16:0 in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;75:2273-2275.
    PubMed    


  106. MEINERTZ T, Munzel T
    Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
    J Am Coll Cardiol. 2020;75:2107-2109.
    PubMed    


    April 2020
  107. HULOT JS, Masurkar N
    miRNA-Based Therapeutics for Heart Failure: Why Not?
    J Am Coll Cardiol. 2020;75:1801-1803.
    PubMed    


  108. REDFORS B, Furer A, Selker HP, Thiele H, et al
    Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    J Am Coll Cardiol. 2020;75:1743-1754.
    PubMed     Abstract available


    March 2020
  109. STEVENSON LW, Naftilan AJ
    Changing the Stage Directions for Heart Failure?
    J Am Coll Cardiol. 2020;75:1439-1442.
    PubMed    


  110. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
    Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1501-1502.
    PubMed    


  111. PALAZZUOLI A, Ruocco G
    Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1500-1501.
    PubMed    


  112. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
    Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1471-1487.
    PubMed     Abstract available


  113. NIJST P, Martens P, Dauw J, Tang WHW, et al
    Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2020;75:1426-1438.
    PubMed     Abstract available


  114. MURPHY SP, Kakkar R, McCarthy CP, Januzzi JL Jr, et al
    Inflammation in Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1324-1340.
    PubMed     Abstract available


  115. CHIRINOS JA, Orlenko A, Zhao L, Basso MD, et al
    Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;75:1281-1295.
    PubMed     Abstract available


  116. ALEXANDER CM
    Is Heart Failure Still the Frequent, Forgotten, and Often Fatal Complication of Diabetes?
    J Am Coll Cardiol. 2020;75:1263-1265.
    PubMed    


  117. KITZMAN DW, Upadhya B, Felker GM
    A Biomarker Approach to Understanding HFpEF.
    J Am Coll Cardiol. 2020;75:1296-1298.
    PubMed    


  118. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
    Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
    J Am Coll Cardiol. 2020;75:1249-1262.
    PubMed     Abstract available


  119. PIRRUCCELLO JP, Bick A, Chaffin M, Aragam KG, et al
    Titin Truncating Variants in Adults Without Known Congestive Heart Failure.
    J Am Coll Cardiol. 2020;75:1239-1241.
    PubMed    


  120. FELKER GM, Ellison DH, Mullens W, Cox ZL, et al
    Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1178-1195.
    PubMed     Abstract available


  121. DEC GW
    Which Drug Will "Lead" in Reducing Cardiac Events Among Heart Failure Patients With Diabetes?
    J Am Coll Cardiol. 2020;75:1142-1144.
    PubMed    


  122. MARSO SP, Baeres FMM, Bain SC, Goldman B, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.
    J Am Coll Cardiol. 2020;75:1128-1141.
    PubMed     Abstract available


  123. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
    Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
    J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
    PubMed    


  124. PAULUS WJ
    Adhesion molecules in early adulthood predict heart failure with preserved ejection fraction at older age.
    J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)34549.
    PubMed    


  125. SELVARAJ S, Claggett BL, Bohm M, Anker SD, et al
    Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.
    J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)30518.
    PubMed     Abstract available


  126. VENTURA HO, Lavie CJ, Mehra MR
    Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal.
    J Am Coll Cardiol. 2020 Mar 10. pii: S0735-1097(20)30620.
    PubMed    


  127. SABBATINI AR, Kararigas G
    Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:1074-1082.
    PubMed     Abstract available


  128. ARNOLD SV, Stone GW, Mack MJ, Chhatriwalla AK, et al
    Health Status Changes and Outcomes in Patients with Heart Failure and Mitral Regurgitation: From COAPT.
    J Am Coll Cardiol. 2020 Mar 4. pii: S0735-1097(20)34413.
    PubMed     Abstract available


  129. BUGIARDINI R, Manfrini O, Cenko E
    Reply: Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction: The Role of S-Nitrosylation.
    J Am Coll Cardiol. 2020;75:989.
    PubMed    


  130. PATANE S
    Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction: The Role of S-Nitrosylation.
    J Am Coll Cardiol. 2020;75:988-989.
    PubMed    


    February 2020
  131. KO DT, Khera R, Lau G, Qiu F, et al
    Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure.
    J Am Coll Cardiol. 2020;75:736-746.
    PubMed     Abstract available


  132. WASFY JH
    A Health Policy and Care Delivery Crisis That We Must Understand Then Fix.
    J Am Coll Cardiol. 2020;75:747-749.
    PubMed    


  133. YANCY CW, Drazner MH, Coffin ST, Cornwell W 3rd, et al
    2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee.
    J Am Coll Cardiol. 2020 Feb 14. pii: S0735-1097(19)37741.
    PubMed    


  134. ZELNIKER TA, Braunwald E
    Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:422-434.
    PubMed     Abstract available


  135. LEE SP, Suh HY, Park S, Oh S, et al
    Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    J Am Coll Cardiol. 2020;75:380-390.
    PubMed     Abstract available


  136. SALDEN FCWM, Luermans JGLM, Westra SW, Weijs B, et al
    Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.
    J Am Coll Cardiol. 2020;75:347-359.
    PubMed     Abstract available


    January 2020
  137. VENTURA HO, Lavie CJ, Mehra MR
    Heart Failure With Preserved Ejection Fraction: Separating the Wheat From the Chaff.
    J Am Coll Cardiol. 2020;75:255-257.
    PubMed    


  138. GOLDHABER SZ
    Venous Thromboembolism in Heart Failure Patients: Pathophysiology, Predictability, Prevention.
    J Am Coll Cardiol. 2020;75:159-162.
    PubMed    


  139. FANOLA CL, Norby FL, Shah AM, Chang PP, et al
    Incident Heart Failure and Long-Term Risk for Venous Thromboembolism.
    J Am Coll Cardiol. 2020;75:148-158.
    PubMed     Abstract available


  140. BISBAL F, Baranchuk A, Braunwald E, Bayes de Luna A, et al
    Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:222-232.
    PubMed     Abstract available


    December 2019
  141. DESWAL A
    Heart Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint.
    J Am Coll Cardiol. 2019;74:2905-2907.
    PubMed    


  142. KOTECHA D, Gill SK, Flather MD, Holmes J, et al
    Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2893-2904.
    PubMed     Abstract available


  143. SHAH AM, Cikes M, Prasad N, Li G, et al
    Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2858-2873.
    PubMed     Abstract available


  144. FONAROW GC, Masson R, Ahmed A
    Reply: What Is Important for Digoxin Treatment in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2827-2828.
    PubMed    


  145. TAN J, Mai L, Zhang Y, Wu Y, et al
    What Is Important for Digoxin Treatment in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2827.
    PubMed    


    November 2019
  146. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    PubMed     Abstract available


  147. CENKO E, van der Schaar M, Yoon J, Manfrini O, et al
    Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:2379-2389.
    PubMed     Abstract available


  148. BRILLER J
    The Feminine Mystique in Myocardial Infarction Associated Mortality.
    J Am Coll Cardiol. 2019;74:2390-2391.
    PubMed    


  149. VADUGANATHAN M, Fonarow GC, Greene SJ, DeVore AD, et al
    Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38082.
    PubMed    


  150. VADUGANATHAN M, Claggett BL, Desai AS, Anker SD, et al
    Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38299.
    PubMed     Abstract available


  151. MARTYN T, Faulkenberg KD, Yaranov DM, Albert CL, et al
    Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output.
    J Am Coll Cardiol. 2019;74:2326-2327.
    PubMed    


  152. GIVERTZ MM, DeFilippis EM, Landzberg MJ, Pinney SP, et al
    Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:2295-2312.
    PubMed     Abstract available


  153. CIAMPI Q, Zagatina A, Cortigiani L, Gaibazzi N, et al
    Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography.
    J Am Coll Cardiol. 2019;74:2278-2291.
    PubMed     Abstract available


    October 2019
  154. AIMO A, Januzzi JL Jr, Bayes-Genis A, Vergaro G, et al
    Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2193-2203.
    PubMed     Abstract available


  155. SUN J, Shang H, Yang X, Xing Y, et al
    Effect of Cardioprotective Drugs on Chemotherapy-Induced Heart Failure and New Risk Stratification.
    J Am Coll Cardiol. 2019;74:1736.
    PubMed    


  156. GOLDSTEIN NE, Mather H, McKendrick K, Gelfman LP, et al
    Improving Communication in Heart Failure Patient Care.
    J Am Coll Cardiol. 2019;74:1682-1692.
    PubMed     Abstract available


    September 2019
  157. ASCH FM, Grayburn PA, Siegel RJ, Kar S, et al
    Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial.
    J Am Coll Cardiol. 2019 Sep 19. pii: S0735-1097(19)37678.
    PubMed     Abstract available


  158. GREENE SJ, Fonarow GC, Butler J
    Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;74:1426-1427.
    PubMed    


  159. DIMMITT SB, Martin JH
    Clinically Optimal Versus "Target" Doses in Heart Failure.
    J Am Coll Cardiol. 2019;74:1425.
    PubMed    


  160. SULLIVAN K, Mamas MA, Van Spall HGC
    Machine Learning Could Facilitate Optimal Titration of Guideline-Directed Medical Therapy in Heart Failure.
    J Am Coll Cardiol. 2019;74:1424-1425.
    PubMed    


  161. CANPOLAT U
    Radial Artery Coronary Bypass Grafting in Heart Failure Patients and Calcium-Channel Blockers.
    J Am Coll Cardiol. 2019;74:1422-1423.
    PubMed    


  162. HOLLENBERG SM, Warner Stevenson L, Ahmad T, Amin VJ, et al
    2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2019 Sep 10. pii: S0735-1097(19)36183.
    PubMed    


  163. JANUZZI JL JR, Ahmad T, Mulder H, Coles A, et al
    Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;74:1205-1217.
    PubMed     Abstract available


    August 2019
  164. MCMURRAY JJV, Docherty KF
    Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?
    J Am Coll Cardiol. 2019;74:902-904.
    PubMed    


  165. SCOTT NJA, Rademaker MT, Charles CJ, Espiner EA, et al
    Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart Failure.
    J Am Coll Cardiol. 2019;74:889-901.
    PubMed     Abstract available


  166. JUJIC A, Melander O, Bergmann A, Hartmann O, et al
    Selenoprotein P Deficiency and Risk of Mortality and Rehospitalization in Acute Heart Failure.
    J Am Coll Cardiol. 2019;74:1009-1011.
    PubMed    


  167. TRIPOSKIADIS F, Xanthopoulos A, Butler J
    Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:804-813.
    PubMed     Abstract available


  168. LEONG DP, McMurray JJV, Joseph PG, Yusuf S, et al
    From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).
    J Am Coll Cardiol. 2019;74:683-698.
    PubMed     Abstract available


  169. JOSEPH P, Swedberg K, Leong DP, Yusuf S, et al
    The Evolution of beta-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5).
    J Am Coll Cardiol. 2019;74:672-682.
    PubMed     Abstract available


  170. MALIK A, Masson R, Singh S, Wu WC, et al
    Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;74:617-627.
    PubMed     Abstract available


  171. CHIRINOS JA
    Discerning the Age-Related Heterogeneity in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:613-616.
    PubMed    


  172. TROMP J, Shen L, Jhund PS, Anand IS, et al
    Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:601-612.
    PubMed     Abstract available


    July 2019
  173. TAYLOR RS, Smart NA, Warren FC, Dalal HM, et al
    Reply: Exercise Capacity Characterization and Physical Activity Intensification Should Be Priorities in Heart Failure Patients.
    J Am Coll Cardiol. 2019;74:590-591.
    PubMed    


  174. LEGGIO M, Tiberti C, Armeni M, Limongelli G, et al
    Exercise Capacity Characterization and Physical Activity Intensification Should Be Priorities in Heart Failure Patients.
    J Am Coll Cardiol. 2019;74:589-590.
    PubMed    


  175. AIMO A, Maisel AS, Castiglione V, Emdin M, et al
    sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff?
    J Am Coll Cardiol. 2019;74:478-479.
    PubMed    


  176. BALDETTI L, Gallone G, Melillo F, Pagnesi M, et al
    Another Call to Address Inflammation in Heart Failure.
    J Am Coll Cardiol. 2019;74:477-478.
    PubMed    


  177. MYHRE PL, Vaduganathan M, Solomon SD
    Reply: Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI.
    J Am Coll Cardiol. 2019;74:165-166.
    PubMed    


  178. KODZISZEWSKA K, Sochanowicz B, Hryniewiecki TT, Witold S, et al
    Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI.
    J Am Coll Cardiol. 2019;74:164-165.
    PubMed    


  179. FOSBOL EL, Rorth R, Leicht BP, Schou M, et al
    Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.
    J Am Coll Cardiol. 2019;74:15-23.
    PubMed     Abstract available


    June 2019
  180. DEVORE AD, Yancy CW
    Heart Failure Management Under Pressure.
    J Am Coll Cardiol. 2019;73:3064-3066.
    PubMed    


  181. ARUNDEL C, Lam PH, Gill GS, Patel S, et al
    Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;73:3054-3063.
    PubMed     Abstract available


  182. AIMO A, Emdin M, Maisel AS
    Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure.
    J Am Coll Cardiol. 2019;73:3038-3039.
    PubMed    


  183. VERGARO G, Passino C, Emdin M
    No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril.
    J Am Coll Cardiol. 2019;73:3037-3038.
    PubMed    


  184. RUBERG FL, Grogan M, Hanna M, Kelly JW, et al
    Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2872-2891.
    PubMed     Abstract available


  185. VAN DER MEER P, Gaggin HK, Dec GW
    ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison.
    J Am Coll Cardiol. 2019;73:2756-2768.
    PubMed     Abstract available


  186. HERZOG CA
    Congestive Heart Failure and Chronic Kidney Disease: The CardioRenal/NephroCardiology Connection.
    J Am Coll Cardiol. 2019;73:2701-2704.
    PubMed    


  187. BANSAL N, Zelnick L, Bhat Z, Dobre M, et al
    Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.
    J Am Coll Cardiol. 2019;73:2691-2700.
    PubMed     Abstract available


  188. SALLOUM FN, Chau VQ
    Osteopontin in HFpEF: More Than Just a Remodeling-Specific Biomarker.
    J Am Coll Cardiol. 2019;73:2719-2721.
    PubMed    


  189. YOUSEFI K, Irion CI, Takeuchi LM, Ding W, et al
    Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
    J Am Coll Cardiol. 2019;73:2705-2718.
    PubMed     Abstract available


    May 2019
  190. BARTKO PE, Arfsten H, Heitzinger G, Pavo N, et al
    A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:2506-2517.
    PubMed     Abstract available


  191. CLELAND JGF, Pellicori P, Clark AL
    Prevention or Procrastination for Heart Failure?: Why We Need a Universal Definition of Heart Failure.
    J Am Coll Cardiol. 2019;73:2398-2400.
    PubMed    


  192. KHAN SS, Ning H, Shah SJ, Yancy CW, et al
    10-Year Risk Equations for Incident Heart Failure in the General Population.
    J Am Coll Cardiol. 2019;73:2388-2397.
    PubMed     Abstract available


  193. BOZKURT B
    Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure.
    J Am Coll Cardiol. 2019;73:2384-2387.
    PubMed    


  194. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    PubMed     Abstract available


  195. GLYNN P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, et al
    Disparities in Cardiovascular Mortality Related to Heart Failure in the United States.
    J Am Coll Cardiol. 2019;73:2354-2355.
    PubMed    


  196. NAGARAJU CK, Robinson EL, Abdesselem M, Trenson S, et al
    Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.
    J Am Coll Cardiol. 2019;73:2267-2282.
    PubMed     Abstract available


  197. DANIELS LB, Bui QM
    Should a High Gal-3 Have Us Scared Stiff?
    J Am Coll Cardiol. 2019;73:2296-2298.
    PubMed    


  198. FRANGOGIANNIS NG
    Can Myocardial Fibrosis Be Reversed?
    J Am Coll Cardiol. 2019;73:2283-2285.
    PubMed    


  199. STIENEN S, Ferreira JP, Vincent J, Busselen M, et al
    Estimated Long-Term Survival With Eplerenone.
    J Am Coll Cardiol. 2019;73:2357-2359.
    PubMed    


  200. PSOTKA MA, Gottlieb SS, Francis GS, Allen LA, et al
    Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2345-2353.
    PubMed     Abstract available


  201. ASLEH R, Enriquez-Sarano M, Jaffe AS, Manemann SM, et al
    Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    J Am Coll Cardiol. 2019;73:2286-2295.
    PubMed     Abstract available


  202. DEL BUONO MG, Arena R, Borlaug BA, Carbone S, et al
    Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2209-2225.
    PubMed     Abstract available


  203. BAYES-GENIS A, Lanfear D
    Liquid Biopsy and eHealth in Heart Failure: The Future Is Now.
    J Am Coll Cardiol. 2019;73:2206-2208.
    PubMed    


  204. UPADHYAY GA, Vijayaraman P, Nayak HM, Verma N, et al
    His Corrective Pacing or Biventricular Pacing for Cardiac Resynchronization in Heart Failure.
    J Am Coll Cardiol. 2019 May 7. pii: S0735-1097(19)34992.
    PubMed    


  205. IUNG B, Messika-Zeitoun D
    Transcatheter Mitral Valve Repair in Secondary MR: New Findings and New Challenges.
    J Am Coll Cardiol. 2019;73:2133-2134.
    PubMed    


  206. WELLS QS, Gupta DK, Smith JG, Collins SP, et al
    Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.
    J Am Coll Cardiol. 2019;73:2195-2205.
    PubMed     Abstract available


  207. SCHLICHTING LE, Insaf TZ, Zaidi AN, Lui GK, et al
    Maternal Comorbidities and Complications of Delivery in Pregnant Women With Congenital Heart Disease.
    J Am Coll Cardiol. 2019;73:2181-2191.
    PubMed     Abstract available


    April 2019
  208. WANG DD
    Dietary Patterns and Precision Prevention of Heart Failure.
    J Am Coll Cardiol. 2019;73:2046-2048.
    PubMed    


  209. LARA KM, Levitan EB, Gutierrez OM, Shikany JM, et al
    Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
    J Am Coll Cardiol. 2019;73:2036-2045.
    PubMed     Abstract available


  210. SANTOS-GALLEGO CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, et al
    Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
    J Am Coll Cardiol. 2019;73:1931-1944.
    PubMed     Abstract available


  211. LEHRKE M
    SGLT2 Inhibition: Changing What Fuels the Heart.
    J Am Coll Cardiol. 2019;73:1945-1947.
    PubMed    


  212. HAUSENLOY DJ, Heusch G
    Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST Action.
    J Am Coll Cardiol. 2019;73:2001-2003.
    PubMed    


  213. THOMAS L, Marwick TH, Popescu BA, Donal E, et al
    Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:1961-1977.
    PubMed     Abstract available


  214. GHORBANI A, Ho JE
    Reply: Galectin-3: A Pathophysiological Background Index or an Emerging Prognostic Biomarker in Heart Failure?
    J Am Coll Cardiol. 2019;73:1875-1876.
    PubMed    


  215. OIKONOMOU E, Siasos G, Tousoulis D
    Galectin-3: A Pathophysiological Background Index or an Emerging Prognostic Biomarker in Heart Failure?
    J Am Coll Cardiol. 2019;73:1875.
    PubMed    


  216. MORROW DA
    The Changing Face of Cardiogenic Shock: A Challenge in Cardiac Critical Care.
    J Am Coll Cardiol. 2019;73:1792-1794.
    PubMed    


  217. LAVIE CJ, Ozemek C, Arena R
    Bringing Cardiac Rehabilitation and Exercise Training to a Higher Level in Heart Failure.
    J Am Coll Cardiol. 2019;73:1444-1446.
    PubMed    


  218. TAYLOR RS, Walker S, Smart NA, Piepoli MF, et al
    Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis.
    J Am Coll Cardiol. 2019;73:1430-1443.
    PubMed     Abstract available


    March 2019
  219. SHAH RV, Das S, Lewis GD
    Circulating MicroRNAs: New Avenues for Heart Failure Classification?
    J Am Coll Cardiol. 2019;73:1314-1316.
    PubMed    


  220. WONG LL, Zou R, Zhou L, Lim JY, et al
    Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    J Am Coll Cardiol. 2019;73:1300-1313.
    PubMed     Abstract available


  221. ANAND IS
    What Explains the Benefits of ARNI Therapy in Heart Failure?
    J Am Coll Cardiol. 2019;73:1285-1287.
    PubMed    


  222. IBRAHIM NE, McCarthy CP, Shrestha S, Gaggin HK, et al
    Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
    J Am Coll Cardiol. 2019;73:1273-1284.
    PubMed     Abstract available


  223. MYHRE PL, Vaduganathan M, Claggett B, Packer M, et al
    B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    J Am Coll Cardiol. 2019;73:1264-1272.
    PubMed     Abstract available


  224. FELDMAN AM
    Precision Medicine for Heart Failure: Back to the Future.
    J Am Coll Cardiol. 2019;73:1185-1188.
    PubMed    


  225. SUCHAROV CC, Nakano SJ, Slavov D, Schwisow JA, et al
    A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.
    J Am Coll Cardiol. 2019;73:1173-1184.
    PubMed     Abstract available


  226. GREENE SJ, Wilson LE, Abbasi SA, Yusuf AA, et al
    Outpatient Intravenous Diuretic Therapy for Heart Failure in the United States.
    J Am Coll Cardiol. 2019;73:1101-1103.
    PubMed    


  227. EVERETT BM, Siddiqi HK
    Heart Failure, the Inflammasome, and Interleukin-1beta: Prognostic and Therapeutic?
    J Am Coll Cardiol. 2019;73:1026-1028.
    PubMed    


  228. PASCUAL-FIGAL DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, et al
    The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.
    J Am Coll Cardiol. 2019;73:1016-1025.
    PubMed     Abstract available


  229. FONAROW GC, Ziaeian B
    Hospital Readmission Reduction Program for Heart Failure: The Spread of Intended and Unintended Consequences.
    J Am Coll Cardiol. 2019;73:1013-1015.
    PubMed    


  230. BLECKER S, Herrin J, Li L, Yu H, et al
    Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure.
    J Am Coll Cardiol. 2019;73:1004-1012.
    PubMed     Abstract available


  231. EBERLY LA, Rusingiza E, Park PH, Ngoga G, et al
    10-Year Heart Failure Outcomes From Nurse-Driven Clinics in Rural Sub-Saharan Africa.
    J Am Coll Cardiol. 2019;73:977-980.
    PubMed     Abstract available


  232. BUTLER J, Yang M, Manzi MA, Hess GP, et al
    Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;73:935-944.
    PubMed     Abstract available


  233. BRESS AP, King JB
    Optimizing Medical Therapy in Chronic Worsening HFrEF: A Long Way to Go.
    J Am Coll Cardiol. 2019;73:945-947.
    PubMed    


  234. VERMA S, Wanner C, Zwiener I, Ofstad AP, et al
    Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2019 Mar 5. pii: S0735-1097(19)33807.
    PubMed    


  235. ARNOLD SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, et al
    Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    J Am Coll Cardiol. 2019 Mar 4. pii: S0735-1097(19)30505.
    PubMed     Abstract available


    February 2019
  236. ZANNAD F, Ferreira JP
    Is Sacubitril/Valsartan Antifibrotic?
    J Am Coll Cardiol. 2019;73:807-809.
    PubMed    


  237. ZILE MR, O'Meara E, Claggett B, Prescott MF, et al
    Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
    J Am Coll Cardiol. 2019;73:795-806.
    PubMed     Abstract available


  238. GREENE SJ, Fonarow GC, DeVore AD, Sharma PP, et al
    Longitudinal Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction: CHAMP-HF Registry.
    J Am Coll Cardiol. 2019 Feb 20. pii: S0735-1097(19)30566.
    PubMed     Abstract available


  239. MCHUGH K, DeVore AD, Wu J, Matsouaka RA, et al
    Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:602-611.
    PubMed     Abstract available


    January 2019
  240. VENTURA HO, Lavie CJ, Mehra MR
    HDL and Heart Failure Regulation: Still Breathing but Exhausted.
    J Am Coll Cardiol. 2019;73:187-189.
    PubMed    


  241. HUNTER WG, McGarrah RW 3rd, Kelly JP, Khouri MG, et al
    High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;73:177-186.
    PubMed     Abstract available


  242. WALSH MN, Jessup M, Lindenfeld J
    Women With Heart Failure: Unheard, Untreated, and Unstudied.
    J Am Coll Cardiol. 2019;73:41-43.
    PubMed    


  243. DEWAN P, Rorth R, Jhund PS, Shen L, et al
    Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.
    J Am Coll Cardiol. 2019;73:29-40.
    PubMed     Abstract available


    December 2018
  244. FELKER GM, Ahmad T
    Biomarkers for the Prevention of Heart Failure: Are We There Yet?
    J Am Coll Cardiol. 2018;72:3255-3258.
    PubMed    


  245. ARNOLD AD, Shun-Shin MJ, Keene D, Howard JP, et al
    His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;72:3112-3122.
    PubMed     Abstract available


    November 2018
  246. BOHM M, Ewen S, Wolf M
    Renal Denervation Halts Left Ventricular Remodeling and Dysfunction in Heart Failure: New Shores Ahead.
    J Am Coll Cardiol. 2018;72:2622-2624.
    PubMed    


  247. SHARP TE 3RD, Polhemus DJ, Li Z, Spaletra P, et al
    Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System.
    J Am Coll Cardiol. 2018;72:2609-2621.
    PubMed     Abstract available


  248. BRUNNER-LA ROCCA HP, Sanders-van Wijk S
    Guiding Heart Failure Therapy After GUIDE-IT: Back to the Drawing Board.
    J Am Coll Cardiol. 2018;72:2563-2566.
    PubMed    


  249. MARK DB, Cowper PA, Anstrom KJ, Sheng S, et al
    Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.
    J Am Coll Cardiol. 2018;72:2551-2562.
    PubMed     Abstract available


  250. AGGARWAL M, Bozkurt B, Panjrath G, Aggarwal B, et al
    Lifestyle Modifications for Preventing and Treating Heart Failure.
    J Am Coll Cardiol. 2018;72:2391-2405.
    PubMed     Abstract available


  251. RICHARDS AM
    ST2 and Prognosis in Chronic Heart Failure.
    J Am Coll Cardiol. 2018;72:2321-2323.
    PubMed    


  252. EMDIN M, Aimo A, Vergaro G, Bayes-Genis A, et al
    sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    J Am Coll Cardiol. 2018;72:2309-2320.
    PubMed     Abstract available


    October 2018
  253. JOLLY SS, Cairns JA, Lavi S, Cantor WJ, et al
    Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial.
    J Am Coll Cardiol. 2018;72:1589-1596.
    PubMed     Abstract available


    September 2018
  254. MERKEN J, Brunner-La Rocca HP, Weerts J, Verdonschot J, et al
    Heart Failure With Recovered Ejection Fraction.
    J Am Coll Cardiol. 2018;72:1557-1558.
    PubMed    


  255. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    PubMed     Abstract available


  256. COLANTONIO LD, Booth JN 3rd, Bress AP, Whelton PK, et al
    2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.
    J Am Coll Cardiol. 2018;72:1187-1197.
    PubMed     Abstract available


  257. GUPTA DK, York MK, Wang TJ
    Reply: Heart Failure, Natriuretic Peptides, and Clinical Practice: Moving Beyond Binary.
    J Am Coll Cardiol. 2018;72:1180-1181.
    PubMed    


  258. DIETSCHE SL, Breidthardt T, Kozhuharov N, Mueller CE, et al
    Heart Failure: It Is Not Just Yes or No.
    J Am Coll Cardiol. 2018;72:1180.
    PubMed    


  259. GOYAL H, Lippi G, Hu ZD
    B-Natriuretic Peptide in Prognosis of Patients With or Without Heart Failure: Impact of Different Assays.
    J Am Coll Cardiol. 2018;72:1179-1180.
    PubMed    


  260. AHMAD T, Wilson FP, Desai NR
    The Trifecta of Precision Care in Heart Failure: Biology, Biomarkers, and Big Data.
    J Am Coll Cardiol. 2018;72:1091-1094.
    PubMed    


  261. TROMP J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, et al
    Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    J Am Coll Cardiol. 2018;72:1081-1090.
    PubMed     Abstract available


  262. DUPREZ DA, Jacobs DR Jr
    Lung Function Decline and Increased Cardiovascular Risk: Quo Vadis.
    J Am Coll Cardiol. 2018;72:1123-1125.
    PubMed    


  263. SILVESTRE OM, Nadruz W Jr, Querejeta Roca G, Claggett B, et al
    Declining Lung Function and Cardiovascular Risk: The ARIC Study.
    J Am Coll Cardiol. 2018;72:1109-1122.
    PubMed     Abstract available


    August 2018
  264. LOPEZ-CANDALES A
    Impact of Left Ventricular Wall Thickness on Global Longitudinal Strain in Acute Heart Failure.
    J Am Coll Cardiol. 2018;72:1066-1067.
    PubMed    


  265. HEYDARI B, Abdullah S, Shah R, Francis SA, et al
    Omega-3 Fatty Acids Effect on Post-Myocardial Infarction ST2 Levels for Heart Failure and Myocardial Fibrosis.
    J Am Coll Cardiol. 2018;72:953-955.
    PubMed    


  266. LUPON J, Gavidia-Bovadilla G, Ferrer E, de Antonio M, et al
    Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure.
    J Am Coll Cardiol. 2018;72:591-601.
    PubMed     Abstract available


    July 2018
  267. URIEL N, Sayer G, Annamalai S, Kapur NK, et al
    Mechanical Unloading in Heart Failure.
    J Am Coll Cardiol. 2018;72:569-580.
    PubMed     Abstract available


  268. ROSENSON RS, Kaul R
    Cardiovascular Outcomes in Persons With HIV and Heart Failure: Medication Class or Suboptimal Viral Suppression?
    J Am Coll Cardiol. 2018;72:531-533.
    PubMed    


  269. ALVI RM, Neilan AM, Tariq N, Awadalla M, et al
    Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.
    J Am Coll Cardiol. 2018;72:518-530.
    PubMed     Abstract available


  270. GREENE SJ, Butler J, Albert NM, DeVore AD, et al
    Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    J Am Coll Cardiol. 2018;72:351-366.
    PubMed     Abstract available


  271. MENTZ RJ, Greene SJ
    Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?
    J Am Coll Cardiol. 2018;72:41-44.
    PubMed    


  272. OBOKATA M, Reddy YNV, Melenovsky V, Kane GC, et al
    Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2018;72:29-40.
    PubMed     Abstract available


    June 2018
  273. FELKER GM, Fudim M
    Unraveling the Mystery of Troponin Elevation in Heart Failure.
    J Am Coll Cardiol. 2018;71:2917-2918.
    PubMed    


  274. LICHSTEIN E, Sharma A
    Changing Endpoints for Heart Failure Studies.
    J Am Coll Cardiol. 2018;71:2653-2655.
    PubMed    


  275. GREENE SJ, O'Brien EC, Mentz RJ, Luo N, et al
    Home-Time After Discharge Among Patients Hospitalized With Heart Failure.
    J Am Coll Cardiol. 2018;71:2643-2652.
    PubMed     Abstract available


  276. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Abstract available


  277. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed    


  278. FARKOUH ME, Verma S
    Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL.
    J Am Coll Cardiol. 2018;71:2507-2510.
    PubMed    


    May 2018
  279. VODOVAR N, Logeart D
    Similar BNP and Mortality Association in Patients With and Without Heart Failure: Any Increase Matters.
    J Am Coll Cardiol. 2018;71:2089-2091.
    PubMed    


  280. YORK MK, Gupta DK, Reynolds CF, Farber-Eger E, et al
    B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
    J Am Coll Cardiol. 2018;71:2079-2088.
    PubMed     Abstract available


  281. PARK JJ, Park JB, Park JH, Cho GY, et al
    Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2018;71:1947-1957.
    PubMed     Abstract available


  282. GORODESKI EZ, Goyal P, Hummel SL, Krishnaswami A, et al
    Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.
    J Am Coll Cardiol. 2018;71:1921-1936.
    PubMed     Abstract available


    April 2018
  283. GONZALEZ A, Schelbert EB, Diez J, Butler J, et al
    Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.
    J Am Coll Cardiol. 2018;71:1696-1706.
    PubMed     Abstract available


  284. BOFFETTA P, Malhotra J
    Impact of Heart Failure on Cancer Incidence: A Complicated Question.
    J Am Coll Cardiol. 2018;71:1511-1512.
    PubMed    


  285. SELVARAJ S, Bhatt DL, Claggett B, Djousse L, et al
    Lack of Association Between Heart Failure and Incident Cancer.
    J Am Coll Cardiol. 2018;71:1501-1510.
    PubMed     Abstract available


    March 2018
  286. PATANE S
    Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors.
    J Am Coll Cardiol. 2018;71:1397.
    PubMed    


  287. VAN VARK LC, Kardys I, Boersma E, Hillege HL, et al
    Reply: Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors.
    J Am Coll Cardiol. 2018;71:1397-1398.
    PubMed    


  288. TAYAL B, Gorcsan J 3rd, Bax JJ, Risum N, et al
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol. 2018;71:1325-1333.
    PubMed     Abstract available


  289. MOGENSEN UM, Kober L, McMurray JJV
    Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1188-1189.
    PubMed    


  290. CANEPA M, Bertero E, Brunelli C, Ameri P, et al
    Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1187-1188.
    PubMed    


  291. KUMMEN M, Mayerhofer CCK, Vestad B, Broch K, et al
    Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts.
    J Am Coll Cardiol. 2018;71:1184-1186.
    PubMed    


  292. LAUTEN A, Dreger H, Schofer J, Grube E, et al
    Caval Valve Implantation for Treatment of Severe Tricuspid Regurgitation.
    J Am Coll Cardiol. 2018;71:1183-1184.
    PubMed    


  293. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    PubMed     Abstract available


  294. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    PubMed     Abstract available


    February 2018
  295. BAJAJ NS, Patel N, Prabhu SD, Arora G, et al
    Effect of NT-proBNP-Guided Therapy on All-Cause Mortality in Chronic Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2018;71:951-952.
    PubMed    


  296. SANO S, Oshima K, Wang Y, MacLauchlan S, et al
    Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1beta/NLRP3 Inflammasome.
    J Am Coll Cardiol. 2018;71:875-886.
    PubMed     Abstract available


  297. ROCHA BML, Cunha GJL, Menezes Falcao LF
    The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.
    J Am Coll Cardiol. 2018;71:782-793.
    PubMed     Abstract available


  298. BORNE Y, Gransbo K, Nilsson J, Melander O, et al
    Vascular Endothelial Growth Factor D, Pulmonary Congestion, and Incidence of Heart Failure.
    J Am Coll Cardiol. 2018;71:580-582.
    PubMed    


    January 2018
  299. O'CONNOR CM, Psotka MA, Fiuzat M, Lindenfeld J, et al
    Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.
    J Am Coll Cardiol. 2018;71:443-453.
    PubMed     Abstract available


  300. TROUGHTON RW, Frampton CMA
    Can Biomarker Panels Predict Response to Pharmacotherapy in Heart Failure?
    J Am Coll Cardiol. 2018;71:399-401.
    PubMed    


  301. OUWERKERK W, Zwinderman AH, Ng LL, Demissei B, et al
    Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    J Am Coll Cardiol. 2018;71:386-398.
    PubMed     Abstract available


  302. MARWICK TH, Ritchie R, Shaw JE, Kaye D, et al
    Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    J Am Coll Cardiol. 2018;71:339-351.
    PubMed     Abstract available


  303. QURESHI WT, Zhang ZM, Chang PP, Rosamond WD, et al
    Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    J Am Coll Cardiol. 2018;71:1-8.
    PubMed     Abstract available


  304. GIBSON CM, Nafee T, Kerneis M
    Silent Myocardial Infarction: Listen to the Evidence.
    J Am Coll Cardiol. 2018;71:9-11.
    PubMed    


    December 2017
  305. SCHUETT K, Kleber ME, Scharnagl H, Lorkowski S, et al
    Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:3202-3204.
    PubMed    


  306. LOGSTRUP BB, Ellingsen T, Pedersen AB, Kjaersgaard A, et al
    Heart Failure and Ischemic Heart Disease in Patients With Rheumatoid Arthritis.
    J Am Coll Cardiol. 2017;70:3069-3071.
    PubMed    


  307. STEINER J, Rodes-Cabau J, Holmes DR Jr, LeWinter MM, et al
    Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:3026-3041.
    PubMed     Abstract available


  308. YANCY CW, Januzzi JL Jr, Allen LA, Butler J, et al
    2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017 Dec 13. pii: S0735-1097(17)41641.
    PubMed    


  309. MCCRINK KA, Maning J, Vu A, Jafferjee M, et al
    Cardiac betaarrestin2 Improves Contractility and Adverse Remodeling in Heart Failure, But Is Underexpressed in Humans.
    J Am Coll Cardiol. 2017;70:2948-2949.
    PubMed    


  310. FARRIS SD, Stempien-Otero A
    Reply: Could the Interplay Between Macrophages and Fibroblasts Drive Extracellular Matrix Dynamics in End-Stage Heart Failure?
    J Am Coll Cardiol. 2017;70:2838-2839.
    PubMed    


  311. DIAS NOVAES R
    Could the Interplay Between Macrophages and Fibroblasts Drive Extracellular Matrix Dynamics in End-Stage Heart Failure?
    J Am Coll Cardiol. 2017;70:2837-2838.
    PubMed    


  312. ERGLIS A, Narbute I, Poupineau M, Hovasse T, et al
    Treatment of Secondary Mitral Regurgitation in Chronic Heart Failure.
    J Am Coll Cardiol. 2017;70:2834-2835.
    PubMed    


  313. LAVIE CJ, Milani RV, Ventura HO
    Adipose Composition and Heart Failure Prognosis: Paradox or Not?
    J Am Coll Cardiol. 2017;70:2750-2751.
    PubMed    


  314. TSUJIMOTO T, Kajio H
    Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.
    J Am Coll Cardiol. 2017;70:2739-2749.
    PubMed     Abstract available


    November 2017
  315. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Abstract available


  316. REDDY YNV, Borlaug BA
    Reply: Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458-2459.
    PubMed    


  317. MESSERLI FH, Rimoldi SF, Wilhelm M
    Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458.
    PubMed    


  318. BAYES-GENIS A, Nunez J, Lupon J
    Soluble ST2 for Prognosis and Monitoring in Heart Failure: The New Gold Standard?
    J Am Coll Cardiol. 2017;70:2389-2392.
    PubMed    


  319. VAN VARK LC, Lesman-Leegte I, Baart SJ, Postmus D, et al
    Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2017;70:2378-2388.
    PubMed     Abstract available


    October 2017
  320. PARIKH NI, Hall PS
    Reply: Hormone Status Correlates With Incidence of Heart Failure.
    J Am Coll Cardiol. 2017;70:2313.
    PubMed    


  321. EL-BATTRAWY I, Borggrefe M, Akin I
    Hormone Status Correlates With Incidence of Heart Failure.
    J Am Coll Cardiol. 2017;70:2312-2313.
    PubMed    


  322. STEINBERG BA, Fang JC
    Long-Term Outcomes of Acute Heart Failure: Where Are We Now?
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39762.
    PubMed    


  323. SHAH KS, Xu H, Matsouaka RA, Bhatt DL, et al
    Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39761.
    PubMed     Abstract available


  324. LEWIS GA, Schelbert EB, Williams SG, Cunnington C, et al
    Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2186-2200.
    PubMed     Abstract available


  325. PASCUAL-FIGAL DA
    Neprilysin and Heart Failure: A "Sympathetic" Relationship?
    J Am Coll Cardiol. 2017;70:2154-2156.
    PubMed    


  326. FRANCIS GS
    Cholesterol and Heart Failure: Is There an Important Connection?
    J Am Coll Cardiol. 2017;70:2137-2138.
    PubMed    


  327. BAYES-GENIS A, Nunez J, Zannad F, Ferreira JP, et al
    The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.
    J Am Coll Cardiol. 2017;70:2128-2136.
    PubMed     Abstract available


  328. POLHEMUS DJ, Trivedi RK, Gao J, Li Z, et al
    Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney.
    J Am Coll Cardiol. 2017;70:2139-2153.
    PubMed     Abstract available


  329. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Reply: Preterm Birth and Risk of Heart Failure in Childhood and Early Adulthood.
    J Am Coll Cardiol. 2017;70:1944-1945.
    PubMed    


  330. BASSAREO PP, Namana V, Fanos V, Mercuro G, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;70:1943-1944.
    PubMed    


  331. KAVALIERATOS D, Gelfman LP, Tycon LE, Riegel B, et al
    Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.
    J Am Coll Cardiol. 2017;70:1919-1930.
    PubMed     Abstract available


  332. KLEIN L
    (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure.
    J Am Coll Cardiol. 2017;70:1887-1889.
    PubMed    


  333. GIVERTZ MM, Stevenson LW, Costanzo MR, Bourge RC, et al
    Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:1875-1886.
    PubMed     Abstract available


  334. LAM PH, Dooley DJ, Deedwania P, Singh SN, et al
    Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:1861-1871.
    PubMed     Abstract available


  335. SCHERRER U, Rexhaj E, Soria R, Meister TA, et al
    Preterm Birth and Risk of Heart Failure: Potential Contribution of Assisted Reproductive Technologies.
    J Am Coll Cardiol. 2017;70:1828-1829.
    PubMed    


  336. WATANABE S, Ishikawa K, Fish K, Oh JG, et al
    Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;70:1744-1756.
    PubMed     Abstract available


    September 2017
  337. LI JG, Xu H
    Should Beta-Blockers Be Routinely Prescribed for Myocardial Infarction Without Heart Failure or Ventricular Dysfunction?
    J Am Coll Cardiol. 2017;70:1685-1686.
    PubMed    


  338. GUAZZI M, Bandera F, Ozemek C, Systrom D, et al
    Cardiopulmonary Exercise Testing: What Is its Value?
    J Am Coll Cardiol. 2017;70:1618-1636.
    PubMed     Abstract available


  339. EL-BATTRAWY I, Borggrefe M, Akin I
    beta-Blockers and Outcome After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1685.
    PubMed    


  340. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Abstract available


  341. SIVAGNANAM K, Mendes LA, Schlendorf KH, Damp JB, et al
    Bridge to Transplantation: Advanced Heart Failure and Transplant Cardiology Training for Cardiovascular Disease Fellows.
    J Am Coll Cardiol. 2017;70:1413-1416.
    PubMed    


  342. FLORAS JS
    Ambulatory Apnea Monitoring in Heart Failure: Proceed With Caution.
    J Am Coll Cardiol. 2017;70:1365-1367.
    PubMed    


  343. EMDIN M, Mirizzi G, Giannoni A, Poletti R, et al
    Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:1351-1364.
    PubMed     Abstract available


  344. LIPSHULTZ SE, Barach PR, Wilkinson JD
    Does Lowering Heart Rate Improve Outcomes in Children With Dilated Cardiomyopathy and Chronic Heart Failure?
    J Am Coll Cardiol. 2017;70:1273-1275.
    PubMed    


  345. BONNET D, Berger F, Jokinen E, Kantor PF, et al
    Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    J Am Coll Cardiol. 2017;70:1262-1272.
    PubMed     Abstract available


    August 2017
  346. TRAVERS JG, Kamal FA, Valiente-Alandi I, Nieman ML, et al
    Pharmacological and Activated Fibroblast Targeting of Gbetagamma-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    J Am Coll Cardiol. 2017;70:958-971.
    PubMed     Abstract available


  347. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed    


  348. ONAT A, Ozbek M, Hayiroglu MI
    Rheumatoid Arthritis and Risk of Nonischemic Heart Failure: Closely Related Common Soil.
    J Am Coll Cardiol. 2017;70:687-688.
    PubMed    


    July 2017
  349. ABDULHADI B, Mezue K, Rangaswami J
    Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:408.
    PubMed    


  350. KONSTAM MA, Udelson JE
    Reply: Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:408-409.
    PubMed    


  351. ABRAHAM WT, Perl L
    Implantable Hemodynamic Monitoring for Heart Failure Patients.
    J Am Coll Cardiol. 2017;70:389-398.
    PubMed     Abstract available


  352. FARRIS SD, Don C, Helterline D, Costa C, et al
    Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
    J Am Coll Cardiol. 2017;70:344-354.
    PubMed     Abstract available


  353. ROGERS JG, Patel CB, Mentz RJ, Granger BB, et al
    Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
    J Am Coll Cardiol. 2017;70:331-341.
    PubMed     Abstract available


  354. BUTLER J, Skopicki H
    Quest for Pathophysiological Understanding of Heart Failure With Preserved Ejection Fraction: Stiffened Resolve, Compliant Approach.
    J Am Coll Cardiol. 2017;70:149-151.
    PubMed    


  355. REDDY YNV, Andersen MJ, Obokata M, Koepp KE, et al
    Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:136-148.
    PubMed     Abstract available


  356. MUNZEL T, Camici GG, Maack C, Bonetti NR, et al
    Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:212-229.
    PubMed     Abstract available


  357. CANNAVO A, Rengo G, Liccardo D, Pun A, et al
    beta1-Blockade Prevents Post-Ischemic Myocardial Decompensation Via beta3AR-Dependent Protective Sphingosine-1 Phosphate Signaling.
    J Am Coll Cardiol. 2017;70:182-192.
    PubMed     Abstract available


    June 2017
  358. MATSUE Y, Damman K, Voors AA, Kagiyama N, et al
    Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
    J Am Coll Cardiol. 2017;69:3042-3051.
    PubMed     Abstract available


  359. SOLOMON SD, Desai AS
    Acute Heart Failure: One Syndrome or Many?
    J Am Coll Cardiol. 2017;69:3040-3041.
    PubMed    


  360. GREENE SJ, Hernandez AF, Dunning A, Ambrosy AP, et al
    Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    J Am Coll Cardiol. 2017;69:3029-3039.
    PubMed     Abstract available


  361. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed    


  362. PINNEY SP, Anyanwu AC, Lala A, Teuteberg JJ, et al
    Left Ventricular Assist Devices for Lifelong Support.
    J Am Coll Cardiol. 2017;69:2845-2861.
    PubMed     Abstract available


  363. DONDO TB, Hall M, West RM, Jernberg T, et al
    beta-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
    J Am Coll Cardiol. 2017;69:2710-2720.
    PubMed     Abstract available


    May 2017
  364. LEESON P, Lewandowski AJ
    A New Risk Factor for Early Heart Failure: Preterm Birth.
    J Am Coll Cardiol. 2017;69:2643-2645.
    PubMed    


  365. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;69:2634-2642.
    PubMed     Abstract available


  366. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Abstract available


  367. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed    


  368. BHATT AS, DeVore AD, DeWald TA, Swedberg K, et al
    Achieving a Maximally Tolerated beta-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
    J Am Coll Cardiol. 2017;69:2542-2550.
    PubMed     Abstract available


  369. SCOTT NS
    Understanding Hormones, Menopause, and Heart Failure: Still a Work in Progress.
    J Am Coll Cardiol. 2017;69:2527-2529.
    PubMed    


  370. HALL PS, Nah G, Howard BV, Lewis CE, et al
    Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative.
    J Am Coll Cardiol. 2017;69:2517-2526.
    PubMed     Abstract available


  371. HANSMANN G
    Pulmonary Hypertension in Infants, Children, and Young Adults.
    J Am Coll Cardiol. 2017;69:2551-2569.
    PubMed     Abstract available


  372. COSTANZO MR, Ronco C, Abraham WT, Agostoni P, et al
    Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research.
    J Am Coll Cardiol. 2017;69:2428-2445.
    PubMed     Abstract available


  373. ZEITLER EP, Friedman DJ, Daubert JP, Al-Khatib SM, et al
    Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;69:2369-2379.
    PubMed     Abstract available


  374. KOSMALA W, Marwick TH
    Reply: Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:2352-2353.
    PubMed    


  375. PEVERILL RE, Gelman JS
    Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:2351-2352.
    PubMed    


  376. KOSMALA W, Marwick TH
    Reply: The Influence of Exercise Therapy on the Heart Failure Disease Pathway.
    J Am Coll Cardiol. 2017;69:2351.
    PubMed    


  377. PAN A
    The Influence of Exercise Therapy on the Heart Failure Disease Pathway.
    J Am Coll Cardiol. 2017;69:2350-2351.
    PubMed    


  378. REDDY VY, Miller MA, Neuzil P, Sogaard P, et al
    Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study.
    J Am Coll Cardiol. 2017;69:2119-2129.
    PubMed     Abstract available


    April 2017
  379. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of
    J Am Coll Cardiol. 2017 Apr 21. pii: S0735-1097(17)37087.
    PubMed    


  380. MENACHEM JN
    Advanced Heart Failure in the ACHD Population: Finding the Fellows' Role in a Growing Field.
    J Am Coll Cardiol. 2017;69:1986-1989.
    PubMed    


  381. JAKOVLJEVIC DG, Yacoub MH, Schueler S, MacGowan GA, et al
    Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1924-1933.
    PubMed     Abstract available


  382. ANDERSEN OS, Smiseth OA, Dokainish H, Abudiab MM, et al
    Estimating Left Ventricular Filling Pressure by Echocardiography.
    J Am Coll Cardiol. 2017;69:1937-1948.
    PubMed     Abstract available


  383. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Abstract available


  384. KOTECHA D, Flather MD, Altman DG, Holmes J, et al
    Heart Rate, Heart Rhythm, and Prognostic Benefits of Beta-Blockers in Heart Failure: Individual Patient-Data Meta-Analysis.
    J Am Coll Cardiol. 2017 Apr 5. pii: S0735-1097(17)36893.
    PubMed     Abstract available


  385. GUAZZI M, Naeije R
    Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    J Am Coll Cardiol. 2017;69:1718-1734.
    PubMed     Abstract available


  386. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Abstract available


  387. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed    


    March 2017
  388. HAVAKUK O, King KS, Grazette L, Yoon AJ, et al
    Heart Failure-Induced Brain Injury.
    J Am Coll Cardiol. 2017;69:1609-1616.
    PubMed     Abstract available


  389. FANG JC, Vidic A
    Central Sleep Apnea in Heart Failure: Sleeping With the Wrong Enemy?
    J Am Coll Cardiol. 2017;69:1588-1591.
    PubMed    


  390. O'CONNOR CM, Whellan DJ, Fiuzat M, Punjabi NM, et al
    Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.
    J Am Coll Cardiol. 2017;69:1577-1587.
    PubMed     Abstract available


  391. YANCY CW
    Acute Heart Failure: Searching for a New Evident Truth.
    J Am Coll Cardiol. 2017;69:1420-1423.
    PubMed    


  392. KONSTAM MA, Kiernan M, Chandler A, Dhingra R, et al
    Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.
    J Am Coll Cardiol. 2017;69:1409-1419.
    PubMed     Abstract available


  393. MITTER SS, Shah SJ, Thomas JD
    A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure.
    J Am Coll Cardiol. 2017;69:1451-1464.
    PubMed     Abstract available


  394. KRUMHOLZ HM, Dhruva SS
    Real World Data on Heart Failure Readmission Reduction: Real or Real Uncertain?
    J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36043.
    PubMed    


  395. HEIDENREICH P
    Inflammation and Heart Failure: Therapeutic or Diagnostic Opportunity?
    J Am Coll Cardiol. 2017;69:1286-1287.
    PubMed    


  396. MANTEL A, Holmqvist M, Andersson DC, Lund LH, et al
    Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;69:1275-1285.
    PubMed     Abstract available


  397. DESAI AS, Bhimaraj A, Bharmi R, Jermyn R, et al
    Reduction in Heart Failure Hospitalizations With Ambulatory Hemodynamic Monitoring Seen in Clinical Trials Is Maintained in the 'Real World'.
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)35978.
    PubMed     Abstract available


  398. PANDEY A, LaMonte M, Klein L, Ayers C, et al
    Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.
    J Am Coll Cardiol. 2017;69:1129-1142.
    PubMed     Abstract available


  399. JESSUP M, Drazner MH, Book W, Cleveland JC Jr, et al
    2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac T
    J Am Coll Cardiol. 2017 Mar 3. pii: S0735-1097(17)30791.
    PubMed    


    February 2017
  400. NAGATOMO Y, McNamara DM, Alexis JD, Cooper LT, et al
    Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against beta1-Adrenergic Receptors.
    J Am Coll Cardiol. 2017;69:968-977.
    PubMed     Abstract available


  401. JANUZZI JL JR, Ibrahim NE
    Renin-Angiotensin System Blockade in Heart Failure: More to the Picture Than Meets the Eye.
    J Am Coll Cardiol. 2017;69:820-822.
    PubMed    


  402. BASU R, Poglitsch M, Yogasundaram H, Thomas J, et al
    Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.
    J Am Coll Cardiol. 2017;69:805-819.
    PubMed     Abstract available


  403. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Abstract available


  404. BAVISHI C, Bangalore S, Messerli FH
    Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients.
    J Am Coll Cardiol. 2017;69:486-493.
    PubMed     Abstract available


    January 2017
  405. GOLDSMITH SR
    Future Study With Tolvaptan in Acute Heart Failure.
    J Am Coll Cardiol. 2017;69:467.
    PubMed    


  406. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Abstract available


  407. DOSHI D, Ben-Yehuda O, Bonafede M, Josephy N, et al
    Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2017;69:364-365.
    PubMed    


  408. SHAH R
    Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2017;69:363-364.
    PubMed    


  409. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Abstract available


  410. HINKEL R, Hoewe A, Renner S, Ng J, et al
    Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.
    J Am Coll Cardiol. 2017;69:131-143.
    PubMed     Abstract available


  411. VAN KIMMENADE RR, Ten Cate TJ, Brunner-La Rocca HP
    Worsening Renal Function in Heart Failure: It Takes 2 to Tangle.
    J Am Coll Cardiol. 2017;69:70-72.
    PubMed    


  412. NG LL, Squire IB, Jones DJ, Cao TH, et al
    Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
    J Am Coll Cardiol. 2017;69:56-69.
    PubMed     Abstract available


  413. REDDY YN, Borlaug BA
    Reply: High-Output Heart Failure: With or Without Obesity.
    J Am Coll Cardiol. 2017;69:113-114.
    PubMed    


  414. CERIT L, Kemal H, Gunsel A, Duygu H, et al
    High-Output Heart Failure: With or Without Obesity.
    J Am Coll Cardiol. 2017;69:112-113.
    PubMed    


  415. JANJUA SA, Triant VA, Addison D, Szilveszter B, et al
    HIV Infection and Heart Failure Outcomes in Women.
    J Am Coll Cardiol. 2017;69:107-108.
    PubMed    


    December 2016
  416. PAVO N, Wurm R, Goliasch G, Novak JF, et al
    Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2912-2914.
    PubMed    


  417. CARBONE S, Canada JM, Buckley LF, Trankle CR, et al
    Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2487-2488.
    PubMed    


  418. MCKIE PM, Burnett JC Jr
    NT-proBNP: The Gold Standard Biomarker in Heart Failure.
    J Am Coll Cardiol. 2016;68:2437-2439.
    PubMed    


  419. ZILE MR, Claggett BL, Prescott MF, McMurray JJ, et al
    Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
    J Am Coll Cardiol. 2016;68:2425-2436.
    PubMed     Abstract available


    November 2016
  420. KOTECHA D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
    J Am Coll Cardiol. 2016;68:2217-2228.
    PubMed     Abstract available


  421. HE GH, Xu GL, Cai WK, Zhang J, et al
    Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
    J Am Coll Cardiol. 2016;68:2029.
    PubMed    


  422. LEARY PJ, Bristow MR
    Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
    J Am Coll Cardiol. 2016;68:2029-2030.
    PubMed    


  423. GIUSTINO G, Redfors B, Brener S, Kirtane A, et al
    TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  424. HALL S, Uriel N, Carey S, Edens M, et al
    TCT-122 Use of the Impella 5.0 circulatory support device for bridge to decision during acute decompensation of advanced heart failure.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  425. PARK Y, Rha SW, Choi BG, Byun JK, et al
    TCT-817 High-Sensitivity C-reactive Protein Predicts New-Onset Heart Failure in Patients Treated with Moderate-Intensity Statin for Primary Prevention.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  426. VAN GILS L, Clavel MA, Vollema M, Delgado V, et al
    TCT-819 Clinical Outcome in Patients with Heart Failure and Moderate Aortic Stenosis.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  427. ANSARI M, Garcia D
    TCT-766 Catheter-Guided Renal Denervation Used For The Treatment Of Heart Failure With Reduced Ejection Fraction: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  428. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  429. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  430. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  431. STONE G, Abraham W, Lindenfeld J, Weissman N, et al
    TCT-627 Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients with Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed    


    October 2016
  432. KOSMALA W, Rojek A, Przewlocka-Kosmala M, Wright L, et al
    Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:1823-1834.
    PubMed     Abstract available


  433. WEVER-PINZON J, Selzman CH, Stoddard G, Wever-Pinzon O, et al
    Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    J Am Coll Cardiol. 2016;68:1741-1752.
    PubMed     Abstract available


  434. SARWAR CM, Papadimitriou L, Pitt B, Pina I, et al
    Hyperkalemia in Heart Failure.
    J Am Coll Cardiol. 2016;68:1575-89.
    PubMed     Abstract available


  435. GUPTA SK, Foinquinos A, Thum S, Remke J, et al
    Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:1557-71.
    PubMed     Abstract available


    September 2016
  436. MAISEL AS, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.
    J Am Coll Cardiol. 2016;68:1420-31.
    PubMed     Abstract available


  437. VON HAEHLING S, Hasenfuss G, Anker SD
    Diabetes and Heart Failure: Sugared Words Prove Bitter.
    J Am Coll Cardiol. 2016;68:1417-9.
    PubMed    


  438. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2016;68:1404-16.
    PubMed     Abstract available


  439. WARING AA, Litwin SE
    Redefining Reverse Remodeling: Can Echocardiography Refine Our Ability to Assess Response to Heart Failure Treatments?
    J Am Coll Cardiol. 2016;68:1277-80.
    PubMed    


  440. STARLING RC, Young JB
    Tolvaptan in Acute Heart Failure: Time to Move On.
    J Am Coll Cardiol. 2016 Sep 15. pii: S0735-1097(16)35324.
    PubMed    


  441. GIERULA J, Paton MF, Byrom R, Cubbon RM, et al
    Reply: The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1253.
    PubMed    


  442. CERIT L
    The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1252-3.
    PubMed    


  443. FELKER GM, Mentz RJ, Cole R, Adams KF, et al
    Efficacy and Safety of Tolvaptan in Patients Hospitalized with Acute Heart Failure.
    J Am Coll Cardiol. 2016 Sep 13. pii: S0735-1097(16)35321.
    PubMed     Abstract available


    July 2016
  444. OPITZ CF, Hoeper MM, Gibbs JS, Kaemmerer H, et al
    Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
    J Am Coll Cardiol. 2016;68:368-78.
    PubMed     Abstract available


  445. BEN-YEHUDA O, Rubin LJ
    Pulmonary Hypertension Overlap Syndromes: A Real Entity?
    J Am Coll Cardiol. 2016;68:379-81.
    PubMed    


    June 2016
  446. SORAJJA P, Pedersen WA, Bae R, Lesser JR, et al
    First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2016;67:2811-8.
    PubMed     Abstract available


    May 2016
  447. BARON SJ, Arnold SV, Herrmann HC, Holmes DR Jr, et al
    Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;67:2349-58.
    PubMed     Abstract available


  448. NAPPI F, Lusini M, Spadaccio C, Nenna A, et al
    Papillary Muscle Approximation Versus Restrictive Annuloplasty Alone for Severe Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2016;67:2334-46.
    PubMed     Abstract available


  449. EGBE AC, Luis SA, Padang R, Warnes CA, et al
    Outcomes in Moderate Mixed Aortic Valve Disease: Is it Time for a Paradigm Shift?
    J Am Coll Cardiol. 2016;67:2321-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: